论文部分内容阅读
目的:评价醋酸曲普瑞林与桂枝茯苓胶囊联用对腹腔镜术后子宫内膜异位症患者的临床疗效。方法:选取2013年—2014年3月间收治的腹腔镜术后子宫内膜异位症患者82例,将其分为对照组和观察组,每组41例;对照组患者均给予醋酸曲普瑞林治疗,观察组患者给予醋酸曲普瑞林与桂枝茯苓胶囊联用治疗,比较两组患者治疗后的总有效率及复发率。结果:观察组临床治疗后的总有效率为97.56%,稍高于对照组为92.68%(P>0.05);观察组患者治疗后痛经症状的复发率为2.50%,低于对照组为18.42%(P<0.05)。结论:醋酸曲普瑞林与桂枝茯苓胶囊联用于治疗腹腔镜术后子宫内膜异位症患者优于醋酸曲普瑞林治疗,且能有效地降低疾病的复发率。
Objective: To evaluate the clinical efficacy of triptorelin acetate and Guizhi Fuling capsule in patients with endometriosis after laparoscopic surgery. Methods: Totally 82 patients with endometriosis after laparoscopic surgery were selected from 2013 to March 2014, and divided into control group and observation group, 41 cases in each group. Patients in the control group were given triptolide In the treatment with Ruilin, the patients in the observation group were treated with triptorelin acetate and Guizhi Fuling capsule, and the total effective rate and recurrence rate after treatment were compared between the two groups. Results: The total effective rate of observation group after treatment was 97.56%, slightly higher than that of control group (92.68%) (P> 0.05). The recurrence rate of dysmenorrhea symptom in observation group was 2.50%, which was lower than that in control group (18.42% (P <0.05). Conclusion: Triptorelin acetate combined with Guizhi Fuling capsule is superior to triptorelin acetate treatment in patients with endometriosis after laparoscopic surgery, and can effectively reduce the recurrence rate of the disease.